We are live on !
Find out more
Wafra Portfolio holdings
AUM
$3.12M
Turnover
0%
1-Year Est. Return
62.35%
This Fund
S&P 500
This Quarter Est. Return
+6.59%
1 Year Est. Return
-62.35%
3 Year Est. Return
-71.49%
5 Year Est. Return
-68.36%
10 Year Est. Return
-20.12%
AUM
$1.95B
AUM Growth
+$102M
(+5.5%)
Cap. Flow
-$12.5M
Cap. Flow % of AUM
Cap. Flow %
-0.64%
Top 10 Holdings %
Top 10 Hldgs %
65.76%
Holding
96
New
12
Increased
20
Reduced
17
Closed
12
Avg Time Held
1.1
years
Top 10 Avg Time Held
0.6
years
Top 20 Avg Time Held
0.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$23.9M |
| 2 |
Procter & Gamble
PG
|
+$16.7M |
| 3 |
Gilead Sciences
GILD
|
+$12.5M |
| 4 |
Nike
NKE
|
+$10.8M |
| 5 |
NiSource
NI
|
+$10M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$18.5M |
| 2 |
Kraft Heinz
KHC
|
+$18.3M |
| 3 |
TWX
Time Warner
TWX
|
+$16.1M |
| 4 |
Dominion Energy
D
|
+$9.5M |
| 5 |
JPMorgan Chase
JPM
|
+$9.08M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 59.14% |
| 2 | Technology | 5.98% |
| 3 | Financials | 5.78% |
| 4 | Healthcare | 5.22% |
| 5 | Consumer Discretionary | 5.19% |
Similar funds
KI
SRB
FM
CPIH
Wafra's Q1 2017 Portfolio in Review
As of Q1 2017, Wafra held 96 positions worth $1.95B, up 5.5% from $1.85B the previous quarter. Its ten largest holdings account for 66% of the portfolio.
Wafra's Q1 2017 filing shows 12 new, 20 increased, 17 reduced and 12 closed positions. Its largest new stake was Gilead Sciences: 178,246 shares worth $12.1M. The largest sale was Allergan plc, an estimated $18.5M.
By sector, the portfolio is most concentrated in Miscellaneous at 59% of assets, up from 59% a quarter earlier, followed by Technology and Financials.
- Wafra's largest Q1 2017 buy was Gilead Sciences: 178,246 shares worth $12.1M.
- Wafra added most to Vanguard FTSE Developed Markets ETF in Q1 2017, an estimated $23.9M increase.
- Wafra's biggest Q1 2017 reduction was JPMorgan Chase, cutting an estimated $9.08M.
- Wafra fully exited Allergan plc in Q1 2017, selling an estimated $18.5M.
- Wafra's ten largest holdings make up 66% of its $1.95B portfolio in Q1 2017.
- Wafra opened 12 new positions and closed 12 in Q1 2017.
- Wafra's portfolio value rose 5.5% quarter-over-quarter to $1.95B.
Based on Wafra's 13F filing for Q1 2017, filed 12 May 2017.